D-1426-2014 Class III Terminated
FDA drug recall D-1426-2014 was initiated by Ferring Pharmaceuticals Inc on Sep 19, 2013 and is designated Class III. Reason for recall: Discoloration; due to prolonged heat exposure. The recall status is terminated (terminated Feb 19, 2015). Affected quantity: 72,046 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 16, 2014
- Initiation Date
- Sep 19, 2013
- Termination Date
- Feb 19, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72,046 cartons
Product description
ENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054 ---- NDC 55566-6500-3
Reason for recall
Discoloration; due to prolonged heat exposure.
Distribution pattern
Nationwide.
Code information
Lot Number:Expiry Date - 0804.182B-1:07/14; 0804.183B-1:07/14; 0804.185A-1:08/14; 0804.186B-1:08/14; 0804.187B-1:08/14; 0804.210A-1:12/14; 0804.212A-1:12/14; 0804.213A-1:12/14; 0804.214A-1:12/14; 0804.216B-1:12/14; 0804.223B-1:02/15 0804.225B-1:03/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1426-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026